Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample. Bulk files are centralized on the Download page.
1-50 of 2,070
Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample.
2,069 ready
| Sample | Organ | Disease state | Cells | Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. | Direction | Propensity | FDR |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_A1,1 | Lung | Primary cancer | 3,505 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.05 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A1,10 | Lung | Primary cancer | 4,001 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.43 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A1,11 | Lung | Primary cancer | 3,063 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.14 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A1,12 | Lung | Primary cancer | 3,476 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.51 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A1,13 | Lung | Primary cancer | 4,327 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.34 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A1,14 | Lung | Primary cancer | 3,473 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.48 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A1,15 | Lung | Primary cancer | 3,465 | Other -> Other | Enriched | 4.78 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A1,16 | Lung | Primary cancer | 2,287 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.01 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A1,17 | Lung | Primary cancer | 1,704 | Stromal -> Stromal | Enriched | 3.38 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A1,2 | Lung | Primary cancer | 4,320 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.71 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A1,3 | Lung | Primary cancer | 2,452 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.94 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A1,4 | Lung | Primary cancer | 3,563 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.53 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A1,6 | Lung | Primary cancer | 2,595 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.67 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A1,7 | Lung | Primary cancer | 3,404 | Other -> Other | Enriched | 4.28 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A1,8 | Lung | Primary cancer | 1,375 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.41 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A1,9 | Lung | Primary cancer | 4,192 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.33 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A2,1 | Lung | Primary cancer | 3,092 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.17 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A2,10 | Lung | Primary cancer | 3,762 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.39 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A2,11 | Lung | Primary cancer | 2,845 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.31 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A2,12 | Lung | Primary cancer | 2,805 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.58 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A2,13 | Lung | Primary cancer | 3,133 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.46 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A2,14 | Lung | Primary cancer | 4,276 | Immune -> Immune | Enriched | 4.67 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A2,15 | Lung | Primary cancer | 1,106 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.11 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A2,16 | Lung | Primary cancer | 3,193 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.08 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A2,17 | Lung | Primary cancer | 1,862 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.78 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A2,2 | Lung | Primary cancer | 2,812 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.47 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A2,3 | Lung | Primary cancer | 2,411 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.19 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A2,4 | Lung | Primary cancer | 3,408 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.08 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A2,5 | Lung | Primary cancer | 2,461 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.73 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A2,6 | Lung | Primary cancer | 2,583 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.77 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A2,7 | Lung | Primary cancer | 3,569 | Immune -> Immune | Enriched | 3.64 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A2,8 | Lung | Primary cancer | 1,237 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.06 | 1.76e-2 |
| NSCLC_38242124__IMC__175_A2,9 | Lung | Primary cancer | 4,350 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.17 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A3,1 | Lung | Primary cancer | 3,603 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.58 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A3,10 | Lung | Primary cancer | 3,114 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.54 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A3,11 | Lung | Primary cancer | 3,134 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.32 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A3,12 | Lung | Primary cancer | 1,916 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.07 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A3,13 | Lung | Primary cancer | 4,214 | Stromal -> Stromal | Enriched | 5.21 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A3,14 | Lung | Primary cancer | 3,209 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.03 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A3,15 | Lung | Primary cancer | 2,343 | Stromal -> Stromal | Enriched | 4.16 | 1.98e-2 |
| NSCLC_38242124__IMC__175_A3,16 | Lung | Primary cancer | 3,374 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.49 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A3,17 | Lung | Primary cancer | 2,434 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.85 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A3,2 | Lung | Primary cancer | 1,903 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.97 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A3,3 | Lung | Primary cancer | 1,345 | Stromal -> Stromal | Enriched | 4.42 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A3,4 | Lung | Primary cancer | 2,091 | Stromal -> Stromal | Enriched | 3.19 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A3,5 | Lung | Primary cancer | 1,902 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.62 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A3,6 | Lung | Primary cancer | 3,058 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.07 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A3,7 | Lung | Primary cancer | 2,576 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.68 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A3,8 | Lung | Primary cancer | 2,287 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.03 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A3,9 | Lung | Primary cancer | 3,607 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.86 | 1.06e-2 |